Cargando…
Metabolic Targets for Treatment of Autoimmune Diseases
There is a considerable unmet demand for safe and efficacious medications in the realm of autoimmune and inflammatory diseases. The fate of the immune cells is precisely governed by control of various metabolic processes such as mitochondrial oxidative phosphorylation, glycolysis, fatty acid synthes...
Autores principales: | Piranavan, Paramarjan, Bhamra, Manjeet, Perl, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184931/ https://www.ncbi.nlm.nih.gov/pubmed/32341806 http://dx.doi.org/10.20900/immunometab20200012 |
Ejemplares similares
-
mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease
por: Perl, Andras
Publicado: (2018) -
Expanding scope of TEMRA in autoimmunity
por: Perl, Andras, et al.
Publicado: (2023) -
Editorial: LINEing Up to Boost Interferon Production: Activation of Endogenous Retroviral DNA in Autoimmunity
por: Perl, Andras
Publicado: (2016) -
Review: Metabolic Control of Immune System Activation in Rheumatic Diseases
por: Perl, Andras
Publicado: (2017) -
Editorial: Mitochondrial dysfunction in inflammation and autoimmunity
por: Staal, Jens, et al.
Publicado: (2023)